Stocktoria
XPENG INC. XPEV
XPENG INC. (XPEV) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $76.7B at a -1.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.77 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-29 | Macquarie | Outperform (up) |
| 2026-03-24 | Barclays | Underweight (main) |
| 2026-03-23 | Macquarie | Neutral (down) |
| 2026-01-06 | Freedom Broker | Buy (up) |
| 2025-08-20 | Citigroup | Buy (main) |
| 2025-08-19 | B of A Securities | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.05 |
| Retained earnings / assets | -0.415 |
| EBIT / assets | -0.027 |
| Equity / liabilities | 0.417 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| XPEV | XPENG INC. | 6/9 | -0.77 | — | +87.7% |
| TSLA | Tesla, Inc. | 5/9 | 4.48 | 375.9 | -2.9% |
| PCAR | PACCAR INC | 3/9 | — | 26.7 | -15.5% |
| LI | Li Auto Inc. | 1/9 | 3.36 | — | -18.8% |
| NIO | NIO Inc. | 4/9 | -4.18 | — | +38.9% |
| OSK | OSHKOSH CORP | 3/9 | 4.7 | — | -2.9% |
| RIVN | Rivian Automotive, Inc. / DE | 4/9 | -4.9 | — | +8.4% |
About XPENG INC.
XPeng Inc. designs, develops, manufactures, and markets smart electric vehicles (EVs) in the People's Republic of China. The company offers P7 and P7i, a four-door sports sedan; G9, a smart EV and a mid- to large-sized sport utility vehicle (SUV); G7 for families and individual consumers seeking advanced technology and comfort; G6, a smart EV and a coupe SUV; X9, Smart EV and a large seven-seater multi-purpose vehicle (MPV); MONA M03, an all-electric hatchback coupe; Next P7, an all-new coupe sports sedan; and P7+, smart EV of XPeng series. It also provides XOS Tianji, smart in-car operating system; Powertrain; and SEPA 2.0, a smart electric platform architecture. In addition, the company offers various services, including services embedded in a sales contract, supercharging, maintenance, technical support, technical research and development, and second-hand vehicle sales services; and insurance technology support, and automotive loan referral and auto financing services. XPeng Inc. was founded in 2015 and is headquartered in Guangzhou, the People's Republic of China.
FAQ
Is XPEV financially healthy?
XPENG INC.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does XPEV pay a dividend?
No, XPENG INC. does not currently pay a dividend.
How profitable is XPEV?
In FY2025, XPENG INC. had a net margin of -1.5% and a return on equity of -3.8%.
What is the analyst price target for XPEV?
The average Wall-Street price target for XPENG INC. is $22.48, about 91.3% above the recent price, from 26 analysts (consensus: buy).
Is XPEV a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on XPENG INC.: a Piotroski F-score of 6/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.